Inhibitors | Comment | Organism | Structure |
---|---|---|---|
BAY 1143572 | novel and highly selective CDK9/P-TEFb inhibitor | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [RNA polymerase II] | Mus musculus | cyclin-dependent kinase 9 (CDK9) is a subunit of the positive transcription elongation factor b (P-TEFb) complex that regulates gene transcription elongation by phosphorylating the C-terminal domain (CTD) of RNA polymerase II | ADP + phospho-[RNA polymerase II] | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | Q99J95 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + [RNA polymerase II] | - |
Mus musculus | ADP + phospho-[RNA polymerase II] | - |
? | |
ATP + [RNA polymerase II] | cyclin-dependent kinase 9 (CDK9) is a subunit of the positive transcription elongation factor b (P-TEFb) complex that regulates gene transcription elongation by phosphorylating the C-terminal domain (CTD) of RNA polymerase II | Mus musculus | ADP + phospho-[RNA polymerase II] | - |
? |
Synonyms | Comment | Organism |
---|---|---|
CDK9 | - |
Mus musculus |
cyclin-dependent kinase 9 | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
drug target | the highly selective CDK9/P-TEFb inhibitor BAY1143572 shows strong potential as a treatment of adult T-cell leukemia/lymphoma (ATL) | Mus musculus |
malfunction | the deregulation of CDK9/PTEFb has important implications for many cancer types | Mus musculus |
metabolism | cyclin-dependent kinase 9 (CDK9) is a subunit of the positive transcription elongation factor b (P-TEFb) complex that regulates gene transcription elongation by phosphorylating the C-terminal domain (CTD) of RNA polymerase II | Mus musculus |